Table 5. Current status of the 75... | American Society of Hematology

Table 5.

Current status of the 75 patients who discontinued IFN-α forever, according to the reasons for treatment discontinuation

Current status	Treatment no longer necessary	Chronic toxicity, loss of compliance	Response loss	Not known	Total
Alive in CCgR	7	15	1^5-150	2	25
Dead in CCgR	1^5-150	4	—	1	6
Alive in PCgR	—	6	—	—	6
Dead in PCgR	—	1	—	1	2
Alive in less than partial CgR	—	5	—	2	7
Dead in less than partial CgR	—	1	—	1	2
Alive in AB phase	—	3	3	—	6
Dead in AB phase	—	1	19^5-151	1	21
Total	8	36	23	8	75

Current status	Treatment no longer necessary	Chronic toxicity, loss of compliance	Response loss	Not known	Total
Alive in CCgR	7	15	1^5-150	2	25
Dead in CCgR	1^5-150	4	—	1	6
Alive in PCgR	—	6	—	—	6
Dead in PCgR	—	1	—	1	2
Alive in less than partial CgR	—	5	—	2	7
Dead in less than partial CgR	—	1	—	1	2
Alive in AB phase	—	3	3	—	6
Dead in AB phase	—	1	19^5-151	1	21
Total	8	36	23	8	75

In 8 cases (first column) the reason was that it was believed that treatment was no longer necessary. In the other cases, treatment discontinuation was decided either because the treatment was no longer tolerated (second column) or because the response had been lost (third column).

F5-150

alloBMT.

F5-151

alloBMT in 3 cases.

View Large

This Feature Is Available To Subscribers Only